Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
暂无分享,去创建一个
Osamu Matsui | Toshifumi Gabata | Tetsuya Minami | Norihide Yoneda | Kotaro Yoshida | O. Matsui | H. Ikeda | Kotaro Yoshida | Hiroko Ikeda | T. Gabata | T. Minami | Dai Inoue | Fumihito Toshima | Takahiro Komori | Norihide Yoneda | D. Inoue | Takahiro Komori | F. Toshima
[1] A. Scarpa,et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. , 2011, Surgery.
[2] C. Lightdale,et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. , 1992, The New England journal of medicine.
[3] C. Doglioni,et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. , 2009, Human pathology.
[4] N. Fukushima. Neuroendocrine Neoplasms of the Pancreas: The PathologicalViewpoint , 2018 .
[5] P. Capelli,et al. Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour , 2013, European Radiology.
[6] Eui Jin Hwang,et al. Intravoxel Incoherent Motion Diffusion-Weighted Imaging of Pancreatic Neuroendocrine Tumors: Prediction of the Histologic Grade Using Pure Diffusion Coefficient and Tumor Size , 2014, Investigative radiology.
[7] M. Falconi,et al. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors , 2011, Neuroendocrinology.
[8] Pierre Bedossa,et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. , 2009, Radiology.
[9] Michael A Choti,et al. NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.
[10] T. McDade,et al. Pancreatic neuroendocrine tumors , 2009, Cancer.
[11] D. Choi,et al. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors , 2014, Acta radiologica.
[12] A. Ferrari,et al. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. , 2004, Gastrointestinal endoscopy.
[13] Hodgkin Lymphoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .
[14] B. Choi,et al. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade , 2013, Abdominal Imaging.
[15] B. Skogseid,et al. Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution , 2008, Clinical Cancer Research.
[16] A. Scarpa,et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system , 2007, Virchows Archiv.
[17] R. Hruban,et al. Tumors of the pancreas , 2007 .
[18] G. Monges,et al. EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. , 2009, Gastrointestinal endoscopy.
[19] D. Sahani,et al. Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. , 2013, Radiology.
[20] Laura H. Tang,et al. Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification , 2011, The American journal of surgical pathology.
[21] J. H. Kim,et al. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour , 2015, European Radiology.
[22] T. Yoshiura,et al. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. , 2015, European journal of radiology.
[23] H. Gouya,et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. , 2003, AJR. American journal of roentgenology.
[24] B. Weinhold. Epigenetics: The Science of Change , 2006, Virchows Archiv.
[25] G. Rindi. 3. The ENETS Guidelines: The New TNM Classification System , 2010, Tumori.
[26] Yi Wang,et al. Diffusion‐weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics , 2011, Journal of magnetic resonance imaging : JMRI.
[27] E. Paal,et al. Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.
[28] A. Scarpa,et al. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. , 2012, Journal of the National Cancer Institute.
[29] V. Vilgrain,et al. Endocrine Pancreatic Tumours and Helical CT: Contrast Enhancement Is Correlated with Microvascular Density, Histoprognostic Factors and Survival , 2006, Pancreatology.
[30] Minhu Chen,et al. Pancreatic neuroendocrine tumours: correlation between MSCT features and pathological classification , 2014, European Radiology.